Impact of Natriuretic Peptide Clearance Receptor (<i>NPR3</i>) Gene Variants on Blood Pressure in Type 2 Diabetes
Pierre‐Jean Saulnier(Inserm), Stéphanie Ragot(Université de Tours), Xavier Prugnard(Centre Hospitalier Universitaire de Poitiers), Dured Dardari(Centre Hospitalier Sud Francilien), Samy Hadjadj(Université de Poitiers), R. Maréchaud(Centre Hospitalier Universitaire de Poitiers), Sulyia Maimaitiming(Inserm), Ronan Roussel(Lyon 1 Université), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Jérémie Lebrec(Inserm), G. Guilloteau(Centre Hospitalier Universitaire d'Angers), Michel Marre(Centre National de la Recherche Scientifique)
Cited by 31
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
|New England Journal of Medicine|2014|624
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
|The Lancet Diabetes & Endocrinology|2017|295
Effect of a diabetic environment in utero on predisposition to type 2 diabetes
|The Lancet|2003|286